ALEMBIC LURASIDONE lurasidone hydrochloride 40 mg film-coated tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

lurasidone hydrochloride, Quantity: 40 mg

Disponibbli minn:

Alembic Pharmaceuticals Australia Pty Ltd

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

28 tablets, 30 Tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Alembic Lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Sommarju tal-prodott:

Visual Identification: White to off white, round shaped, biconvex, film-coated tablets debossed with 516 on one side and L on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2020-06-24